Developing a Digital Medicine System in Psychiatry: Ingestion Detection Rate and Latency Period.
暂无分享,去创建一个
[1] George M. Savage,et al. An Ingestible Sensor for Measuring Medication Adherence , 2015, IEEE Transactions on Biomedical Engineering.
[2] Roy H Perlis,et al. First experience with a wireless system incorporating physiologic assessments and direct confirmation of digital tablet ingestions in ambulatory patients with schizophrenia or bipolar disorder. , 2013, The Journal of clinical psychiatry.
[3] R. Reves,et al. Feasibility of an Ingestible Sensor-Based System for Monitoring Adherence to Tuberculosis Therapy , 2013, PloS one.
[4] G. Oster,et al. Medication adherence and utilization in patients with schizophrenia or bipolar disorder receiving aripiprazole, quetiapine, or ziprasidone at hospital discharge: A retrospective cohort study , 2012, BMC Psychiatry.
[5] J. Vázquez-Barquero,et al. Predicting relapse after a first episode of non-affective psychosis: a three-year follow-up study. , 2012, Journal of psychiatric research.
[6] R. Reves,et al. Early clinical experience with networked system for promoting patient self-management. , 2011, The American journal of managed care.
[7] D. Faries,et al. Adherence and persistence with branded antidepressants and generic SSRIs among managed care patients with major depressive disorder , 2011, ClinicoEconomics and outcomes research : CEOR.
[8] P. Weiden,et al. Measurement of psychiatric treatment adherence. , 2010, Journal of psychosomatic research.
[9] Josep Maria Haro,et al. Predictors and clinical consequences of non-adherence with antipsychotic medication in the outpatient treatment of schizophrenia , 2010, Psychiatry Research.
[10] R. Conley,et al. The cost of relapse and the predictors of relapse in the treatment of schizophrenia , 2010, BMC psychiatry.
[11] Mark Taylor,et al. Attitudes of patients and mental health staff to antipsychotic long-acting injections: Systematic review , 2009, British Journal of Psychiatry.
[12] J. Haro,et al. PMH25 CLINICAL AND ECONOMIC CONSEQUENCES OF MEDICATION NONADHERENCE IN THE TREATMENT OF PATIENTS WITH A MANIC/ MIXED EPISODE OF BIPOLAR DISORDER: RESULTS FROM THE EUROPEAN MANIA IN BIPOLAR LONGITUDINAL EVALUATION OF MEDICATION (EMBLEM) STUDY , 2009 .
[13] A. Caballero-Hidalgo,et al. Evaluation of noncompliance in schizophrenia patients using electronic monitoring (MEMS®) and its relationship to sociodemographic, clinical and psychopathological variables , 2009, Schizophrenia Research.
[14] W. Riley,et al. Adherence to psychiatric treatments , 2009 .
[15] T. Carmody,et al. Validity of electronically monitored medication adherence and conventional adherence measures in schizophrenia. , 2007, Psychiatric services.
[16] M. Swartz,et al. Medication adherence and long-term functional outcomes in the treatment of schizophrenia in usual care. , 2006, The Journal of clinical psychiatry.
[17] Alexander L. Miller,et al. Defining and assessing adherence to oral antipsychotics: a review of the literature. , 2005, Schizophrenia bulletin.
[18] Christian R. Dolder,et al. Prevalence of and risk factors for medication nonadherence in patients with schizophrenia: a comprehensive review of recent literature. , 2002, The Journal of clinical psychiatry.